Bispecific antibodies against human TWEAK and human IL17 and uses thereof

US9714292B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Johannes Auer · Schwaigen, DE
• Martin Bader · Penzberg, DE
• Jens Fischer · Penzberg, DE
• Hubert Kettenberger · Munich, DE
• Maximiliane Koenig · Pullach, DE
• Stefan Lorenz · Penzberg, DE
• Joerg Moelleken · Penzberg, DE

Key dates

• Filing date: Oct 3, 2014
• Grant date: Jul 25, 2017
• Expiry date: Oct 3, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/94
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to Bispecific antibodies against human TWEAK and human IL17 (bispecific TWEAK-IL17 antibodies), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.